Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Dec 1, 2023. (Total: 223474Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 7 (of 7 Records)

Query Trace: Achievement and NPM1[original query]
Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B.
Haematologica 2009 Jan 94 (1): 54-60.
Schlenk Richard F, Döhner Konstanze, Kneba Michael, Götze Katharina, Hartmann Frank, Del Valle Francesco, Kirchen Heinz, Koller Elisabeth, Fischer Jörg T, Bullinger Lars, Habdank Marianne, Späth Daniela, Groner Silja, Krebs Bernhard, Kayser Sabine, Corbacioglu Andrea, Anhalt Andreas, Benner Axel, Fröhling Stefan, Döhner Hartmut,
NPM1 but not FLT3-ITD mutations predict early blast cell clearance and CR rate in patients with normal karyotype AML (NK-AML) or high-risk myelodysplastic syndrome (MDS).
Blood 2009 May 113 (21): 5250-3.
Schneider Friederike, Hoster Eva, Unterhalt Michael, Schneider Stephanie, Dufour Annika, Benthaus Tobias, Mellert Gudrun, Zellmeier Evelin, Bohlander Stefan K, Feuring-Buske Michaela, Buske Christian, Braess Jan, Fritsch Susanne, Heinecke Achim, Sauerland Maria C, Berdel Wolfgang E, Buechner Thomas, Woermann Bernhard J, Hiddemann Wolfgang, Spiekermann Karst
The prognostic value of CXCR4 in acute myeloid leukemia.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2013 Jan 21 (1): 79-84.
Ahn Jeong Yeal, Seo Katie, Weinberg Olga K, Arber Daniel
MRD assessed by WT1 and NPM1 transcript levels identifies distinct outcomes in AML patients and is influenced by gemtuzumab ozogamicin.
Oncotarget 2014 Aug 5 (15): 6280-8.
Lambert Juliette, Lambert Jérôme, Nibourel Olivier, Pautas Cécile, Hayette Sandrine, Cayuela Jean-Michel, Terré Christine, Rousselot Philippe, Dombret Hervé, Chevret Sylvie, Preudhomme Claude, Castaigne Sylvie, Renneville Ali
High EVI1 Expression Predicts Poor Outcomes in Adult Acute Myeloid Leukemia Patients with Intermediate Cytogenetic Risk Receiving Chemotherapy.
Medical science monitor : international medical journal of experimental and clinical research 2018 2 24 758-767.
Qin Ya-Zhen, Zhao Ting, Zhu Hong-Hu, Wang Jing, Jia Jin-Song, Lai Yue-Yun, Zhao Xiao-Su, Shi Hong-Xia, Liu Yan-Rong, Jiang Hao, Huang Xiao-Jun, Jiang Qi
High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG).
Cancers 2020 8 12 (8): .
Salmoiraghi Silvia, Cavagna Roberta, Zanghì Pamela, Pavoni Chiara, Michelato Anna, Buklijas Ksenija, Elidi Lara, Intermesoli Tamara, Lussana Federico, Oldani Elena, Caprioli Chiara, Stefanoni Paola, Gianfaldoni Giacomo, Audisio Ernesta, Terruzzi Elisabetta, De Paoli Lorella, Borlenghi Erika, Cavattoni Irene, Mattei Daniele, Scattolin Annamaria, Tajana Monica, Ciceri Fabio, Todisco Elisabetta, Campiotti Leonardo, Corradini Paolo, Fracchiolla Nicola, Bassan Renato, Rambaldi Alessandro, Spinelli Oriet
High WT1 expression predicted induction chemotherapy failure in acute myeloid leukemia patients with non-favorable cytogenetic risk.
Clinical and experimental medicine 2023 1 .
Xu Nan, Chen Wen-Min, Li Ling-Di, Long Ling-Yu, Wang Xu, Jiang Qian, Jiang Hao, Huang Xiao-Jun, Qin Ya-Zh
TOP